hematopoietic system
• 1.9-fold increase in the frequency of plasmacytoid dendritic cells (pDCs) in the lymph nodes and among total live cells and in their absolute numbers
• the pDC accumulation in the lymph nodes results from both enhanced egress from the bone marrow and enhanced pDC survival
• however, the proportion of B cell and conventional dendritic cells (cDC) populations in the periphery or macrophages is mostly unchanged
• mice induced to develop experimental autoimmune encephalomyelitis show an increase in pDC frequencies in the bone marrow and lymph nodes and in the brain and spinal cord
|
immune system
• 1.9-fold increase in the frequency of plasmacytoid dendritic cells (pDCs) in the lymph nodes and among total live cells and in their absolute numbers
• the pDC accumulation in the lymph nodes results from both enhanced egress from the bone marrow and enhanced pDC survival
• however, the proportion of B cell and conventional dendritic cells (cDC) populations in the periphery or macrophages is mostly unchanged
• mice induced to develop experimental autoimmune encephalomyelitis show an increase in pDC frequencies in the bone marrow and lymph nodes and in the brain and spinal cord
|
• pDCs from the spleen show lower intracellular levels of IFN-alpha and TNF-alpha when stimulated with CpG ODN1585, a synthetic ligand for Toll-like receptor 9, indicating aberrant cytokine production by pDCs
• pDCs derived from EAE-induced mice express lower levels of IFN-gamma, IL-6, and TNF-alpha following CpGA stimulation
|
• mice show a delayed onset of experimental autoimmune encephalomyelitis (EAE) and milder disease following induction with myelin oligodendrocyte glycoprotein 33-55 peptide
|